Stockreport

Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx) [Yahoo! Finance]

Axogen, Inc.  (AXGN) 
Last axogen, inc. earnings: 2/24 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.axogeninc.com
PDF ALACHUA, Fla. and TAMPA, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical technologie [Read more]